Reinke, Petra

Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines

Moll, G., Ankrum, J. A., Kamhieh-Milz, J., Bieback, K., Ringdén, O., Volk, H.-D., Geissler, S., & Reinke, P. (2019) · Trends in Molecular Medicine

Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cited by 440

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population

Wagner, D. L., Amini, L., Wendering, D. J., Burkhardt, L.-M., Akyüz, L., Reinke, P., Volk, H.-D., & Schmueck-Henneresse, M. (2019) · Nature Medicine

CRISPR and Genetic EngineeringT-cell and B-cell Immunology

Cited by 399

Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional Properties

Andrzejewska, A., Catar, R., Schoon, J., Qazi, T. H., Sass, F. A., Jacobi, D., Blankenstein, A., Reinke, S., Krüger, D., Streitz, M., et al. (2019) · Frontiers in Immunology

Mesenchymal stem cell researchHematopoietic Stem Cell Transplantation

Cited by 89

Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs

Abou-El-Enein, M., Römhild, A., Kaiser, D., Beier, C., Bauer, G., Volk, H.-D., & Reinke, P. (2013) · Cytotherapy

Pharmaceutical Economics and PolicyBiomedical Ethics and Regulation

Cited by 86

Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome

Loebel, M., Strohschein, K., Giannini, C., Koelsch, U., Bauer, S., Doebis, C., Thomas, S., Unterwalder, N., von Baehr, V., Reinke, P., et al. (2014) · PLoS ONE

Fibromyalgia and Chronic Fatigue Syndrome ResearchViral-associated cancers and disorders

Cited by 86

Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells

Glaser, V., Flugel, C., Kath, J., Du, W., Drosdek, V., Franke, C., Stein, M., Pruß, A., Schmueck-Henneresse, M., Volk, H.-D., et al. (2023) · Genome biology

CRISPR and Genetic EngineeringCAR-T cell therapy research

Cited by 65

Putting a price tag on novel autologous cellular therapies

Abou-El-Enein, M., Bauer, G., Medcalf, N., Volk, H.-D., & Reinke, P. (2016) · Cytotherapy

Pharmaceutical Economics and PolicyCAR-T cell therapy research

Cited by 44

Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial

Viklicky, O., Hruba, P., Tomiuk, S., Schmitz, S., Gerstmayer, B., Sawitzki, B., Miqueu, P., Mrazova, P., Tycova, I., Svobodova, E., et al. (2017) · PLOS ONE

Renal Transplantation Outcomes and TreatmentsTransplantation: Methods and Outcomes

Cited by 12